N6-Methyladenosine (m6A) Modification Activates Serine Synthesis Pathway to Mediate Therapeutic Resistance in Liver Cancer

Using GLORI-seq, scientists delineated a single-base resolution m6A landscape in human HCC cell lines. They identified three core enzymes in the serine synthesis pathway as novel targets of METTL3-mediated m6A modification.